Following its submission of the Premarket Tobacco Product Application (PMTA) to
America’s Food & Drug Administration (FDA) last summer, JUUL Labs focussed on completing a swathe of peer-reviewed research.
The company has just published 11 studies in a monograph edition of the American Journal of Health Behavior (AJHB). JUUL Labs told POTV that it is, “committed to working collaboratively with regulators, policymakers, public health leaders, and other stakeholders as we work to reset the category and company and strive to earn a license to operate in society. This includes scientific exchange with these stakeholders as we advance a science and evidence-based dialogue.”
Its PMTA to the FDA contained:
- Over 110 original scientific studies
- Over 125,000 pages of data
The information included detail of how JUUL pods impact on individual users, how they help to help adult smokers switch to vaping, and the net-population impact on public health.
Dave Cross – Planet of the Vapes – 2021-05-06.
Want More Investigative Content?
